SCHEMBL19705770

SCHEMBL19705770

CC[C@H](COCCC[Si](C)(C)O)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 16/20 0.70
▸ CDK2 P24941 14/20 0.70
▸ CDK7 P50613 12/20 0.70
▸ CCNE1 P24864 12/20 0.70
▸ CDK5 Q00535 9/20 0.70
▸ CDK4 P11802 9/20 0.70
▸ CCNB1 P14635 9/20 0.70
▸ CCND1 P24385 9/20 0.70
▸ CCNH P51946 9/20 0.70
▸ MAPK1 P28482 6/20 0.70
▸ CDK9 P50750 4/20 0.70
▸ CSNK1D P48730 2/20 0.70
▸ CLK2 P49760 2/20 0.70
▸ CSNK1G2 P78368 2/20 0.70
▸ DYRK1A Q13627 2/20 0.70
▸ CLK4 Q9HAZ1 2/20 0.70
▸ CSNK1G1 Q9HCP0 2/20 0.70
▸ CCNK O75909 2/20 0.70
▸ CCNE2 O96020 2/20 0.70
▸ CCNA2 P20248 2/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16366290 0.87 CDK1 (0.78) CDK1CDK2CDK7CCNE1CDK5
SCHEMBL13498207 0.86 CDK1 (0.79) CDK1CDK2CDK7CCNE1CDK5
SCHEMBL20383010 0.85 CDK1 (0.81) CDK1CDK2CDK7CCNE1CDK5
SCHEMBL14403894 0.84 CDK1 (0.88) CDK1CDK2CDK7CCNE1CDK5
SCHEMBL13497862 0.84 CDK1 (0.78) CDK1CDK2CDK7CCNE1CDK5
(S)-Roscovitine SCHEMBL29415376 0.83 CDK1 (1.00) CDK1CDK2CDK7CCNE1CDK5
(Rs)-Roscovitine SCHEMBL172593 0.83 CDK1 (1.00) CDK1CDK2CDK7CCNE1CDK5
(Rs)-Roscovitine SCHEMBL15163619 0.83 CDK1 (1.00) CDK1CDK2CDK7CCNE1CDK5
(S)-Roscovitine SCHEMBL2907488 0.83 CDK1 (1.00) CDK1CDK2CDK7CCNE1CDK5
Seliciclib SCHEMBL94728 0.83 CDK1 (1.00) CDK1CDK2CDK7CCNE1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220184104-A1 SILANOL BASED THERAPEUTIC PAYLOADS BLINKBIO INC (US) 2022-06-16 — — US disclosed
US-20210161921-A1 Silanol Based Therapeutic Payloads BLINKBIO, INC. 2021-06-03 — — US disclosed
US-10716801-B2 Silanol based therapeutic payloads BLINKBIO, INC. (US) 2020-07-21 — — US disclosed
US-20190183913-A1 Silanol Based Therapeutic Payloads BLINKBIO INC (US) 2019-06-20 — — US disclosed
US-10293053-B2 Silanol based therapeutic payloads BLINKBIO, INC. (US) 2019-05-21 — — US disclosed
US-20190111142-A1 Silanol Based Therapeutic Payloads BLINKBIO, INC. (US) 2019-04-18 — — US disclosed
US-20180200273-A1 Silanol Based Therapeutic Payloads BLINKBIO INC (US) 2018-07-19 — — US disclosed
US-20180200273-A1 Silanol Based Therapeutic Payloads BLINKBIO INC (US) 2018-07-19 — — US disclosed
WO-2017214491-A1 SILANOL BASED THERAPEUTIC PAYLOADS BLINKBIO, INC. (US) 2017-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190183913-A1 Silanol Based Therapeutic Payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-20210161921-A1 Silanol Based Therapeutic Payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-10716801-B2 Silanol based therapeutic payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-20180200273-A1 Silanol Based Therapeutic Payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-10293053-B2 Silanol based therapeutic payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-20190111142-A1 Silanol Based Therapeutic Payloads CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885
US-20220184104-A1 SILANOL BASED THERAPEUTIC PAYLOADS CD47, CD4, BST2 CDK1 3761/4885CDK2 3576/4885CDK7 4392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback